Notícias Eulerpool Novartis

Novartis Eulerpool-AFX

Novartis Notícias de ações

Novartis é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de Novartis nós reunimos aqui.

• 31 de maio ·

  Yahoo
  Novartis (NVS) Reports Positive Long-Term Data on CSU Drug
• 31 de maio ·

  PR Newswire
  Navigate BioPharma Services, Inc. Launch Assay for Precise Measurement of Radioligand Therapy Response in Tumors
• 31 de maio ·

  Alliance News
  Novartis celebrates positive data for Scemblix, remibrutinib, Kisqali
• 31 de maio ·

  Yahoo
  Novartis Scemblix® Phase III data first to show superior efficacy with a favorable safety and tolerability profile vs. standard-of-care TKIs in adults with newly diagnosed CML
• 31 de maio ·

  Seeking Alpha
  Novartis boasts Scemblix beats tyrosine kinase inhibitors for chronic myeloid leukemia
• 31 de maio ·

  Yahoo
  Novartis reports Phase III data for trials of remibrutinib to treat CSU
• 31 de maio ·

  Seeking Alpha
  Novartis reports positive Phase 3 data for remibrutinib for chronic hives
• 31 de maio ·

  Benzinga
  Novartis' Oral Drug For Chronic Skin Disease Candidate Shows Efficacy, Long-term Safety
• 31 de maio ·

  Yahoo
  Novartis study points to larger role for targeted leukemia drug
• 31 de maio ·

  Thefly.com
  Novartis announces its Phase III study of Scemblix showed 'superior efficacy'